Vistos Co., Ltd
Financials
Valuation Metrics
Vistos Co., Ltd's Market Cap is ₩178B. At end of 2025 it was ₩319B. Ranked #2359 of 2,436 in KR market (top 97%), #1580 of 1,649 on KOSDAQ (top 96%), #96 of 96 in Health Care Equipment & Services (top 100%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 17.76B KRW | KR#2,359/2,436 Sec#96/96 |
| Revenue | 16.36B KRW | KR#2,187/2,436 Sec#74/96 |
| Net Income | -454.3M KRW | KR—/2,436 Sec—/96 |
| Total Assets | 25.85B KRW | KR#2,346/2,436 Sec#91/96 |
| Net Assets | 17.61B KRW | KR#2,306/2,436 Sec#91/96 |
| Employees | 69 | KR#1,867/2,436 Sec#74/96 |
| Value | ||
| P/B | 1.01x | KR#1,494/2,436 Sec#42/96 |
| P/S | 1.09x | KR#1,456/2,436 Sec#32/96 |
| FCF Yield | -12.43% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | -2.58% | KR#1,651/2,436 Sec#56/96 |
| ROA | -1.76% | KR#1,679/2,436 Sec#56/96 |
| Op. Margin | -5.56% | KR#1,883/2,436 Sec#58/96 |
| Revenue Growth | -19.94% | KR#2,065/2,436 Sec#81/96 |
| Earnings Growth | -194.40% | KR#1,492/2,436 Sec#50/96 |
| Financial Health | ||
| Debt Ratio | 146.80% | KR#1,146/2,436 Sec#58/96 |
| Total Debt | 3.12B KRW | KR#1,851/2,436 Sec#67/96 |
| FCF | -2.21B KRW | KR#1,353/2,436 Sec#42/96 |
| Cash | 3.78B KRW | KR#2,088/2,436 Sec#80/96 |
| Current Ratio | 2.03x | KR#932/2,436 Sec#49/96 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,436 Sec—/96 |
| Performance | ||
| 1Y Return | -57.31% | KR#2,199/2,436 Sec#80/96 |
| 1M Return | -9.83% | KR#1,748/2,436 Sec#70/96 |
| From 52W High | -74.09% | KR#2,260/2,436 Sec#86/96 |
| 1Y MDD | -78.67% | KR#2,264/2,436 Sec#91/96 |
| Trading | ||
| Volume | 21,403 shares | KR#1,814/2,436 Sec#73/96 |
| Foreign Own. | 0.89% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | -99 KRW | KR—/2,436 Sec—/96 |
| BPS | 3,932 KRW | KR#1,622/2,436 Sec#41/96 |
Company Info
Bistos, established in 2001, specializes in manufacturing medical devices, particularly for fetal and neonatal care, including fetal monitors, jaundice therapy devices, and incubators, and was listed on KOSDAQ in 2022. Over 90% of its sales come from exports to over 120 countries. The company is expanding into home medical devices like breast pumps and thermometers, patient monitors, and aims to become a leader in biosignal technology by exploring ADHD/dementia treatment and wearable healthcare. Bistos is headquartered in Gyeonggi-do, Seongnam-si.